ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 300

$516K Total Retail Price of All Prescriptions

Rank: 42 out of 300

510 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 7,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL TARTRATE 514 387 1 13
FUROSEMIDE 471 390 2 3
AMLODIPINE BESYLATE 339 309 3 2
SIMVASTATIN 337 292 4 5
CARVEDILOL 333 301 5 12
CLOPIDOGREL 291 238 6 18
WARFARIN SODIUM 251 223 7 10
LISINOPRIL 246 231 8 4
ATORVASTATIN CALCIUM 241 205 9 14
PLAVIX 238 195 10 24
EFFIENT 225 199 11 221
ISOSORBIDE MONONITRATE ER 215 187 12 32
METOPROLOL SUCCINATE 202 186 13 6
BYSTOLIC 180 166 14 59
PRAVASTATIN SODIUM 173 149 15 15
PRADAXA 170 133 16 108
RAMIPRIL 143 112 17 63
SPIRONOLACTONE 140 123 18 92
OMEPRAZOLE 131 112 19 11
POTASSIUM CHLORIDE 122 99 20 22
RANEXA 107 98 21 124
BUMETANIDE 105 90 22 126
CILOSTAZOL 93 92 23 182
SOTALOL 92 76 24 133
DILTIAZEM ER 85 81 25 198
NEXIUM 85 72 25 17
CLONIDINE HCL 83 69 27 50
NITROSTAT 76 66 28 157
AMIODARONE HCL 73 53 29 96
LIPITOR 69 53 30 115
PANTOPRAZOLE SODIUM 66 60 31 35
ESCITALOPRAM OXALATE 65 56 32 78
LOSARTAN POTASSIUM 65 65 32 29
MECLIZINE HCL 61 61 34 147
MULTAQ 59 33 35 177
ATENOLOL 59 36 35 31
NIASPAN 56 56 37 183
DOXAZOSIN MESYLATE 53 53 38 90
LOVASTATIN 51 36 39 68
DIOVAN 50 50 40 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.